Skip to main content
Clinical Trials/CTRI/2023/04/051590
CTRI/2023/04/051590
Not yet recruiting
未知

Comparison of efficacy and safety of short-term low dose 0.03% Tacrolimus eye ointment versus 0.5% Loteprednol etabonate eye drops as first choice in patients with mild to moderate bilateral Vernal keratoconjunctivitis. - TALO

KLE JGMM Medical College and Suchirayu Hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: H104- Chronic conjunctivitis
Sponsor
KLE JGMM Medical College and Suchirayu Hospital
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
KLE JGMM Medical College and Suchirayu Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\.Age more than 14 years
  • 2\.Active Bilateral Mild to Moderate Vernal Kerato Conjunctivitis

Exclusion Criteria

  • 1\.Patients with adenexal abnormalities , glaucoma, contact lens wearer, corneal pathology
  • 2\.Patients on immunosuppressive therapy.
  • 3\.known hypersensitivity to Tacrolimus eye ointment
  • 4\.Pregnancy and Lactation
  • 5\.History of topical medication usage in the previous two weeks.

Outcomes

Primary Outcomes

Not specified

Similar Trials